Breast cancer, a woman’s most feared disease, is the second most frequently treated cancer at UCSF. October -- breast cancer awareness month – is an opportune time to take stock of recent progress at UCSF, home to one of the nation’s preeminent cancer centers.
September 30, 2011
July 05, 2011
Mammograms should not be done on a one-size fits all basis, but instead should be personalized based on a woman’s age, the density of her breasts, her family history of breast cancer and other factors including her own values, according to a new study.
December 13, 2010
UCSF physicians are combating a devastating side effect of chemotherapy with an innovative new program -- “Hair to Stay” -- to evaluate devices that could reduce scalp hair loss in breast cancer patients.
November 29, 2010
In a new UCSF study of more than 2 million mammogram screenings performed on nearly 700,000 women in the United States, scientists for the first time show a direct link between reduced hormone therapy and declines in ductal carcinoma in situ (DCIS) as well as invasive breast cancer.
October 25, 2010
A UCSF cancer education project has received the 2010 Faith Fancher Award from the California Breast Cancer Research Program, as well as a $600,000 grant recognizing the best proposal focused on underserved populations.
September 24, 2010
Basic physical limitations following breast cancer treatment can have far-reaching consequences that substantially affect how long a patient lives.
June 07, 2010
A single dose of radiation administered during surgery is as effective for patients with early forms of breast cancer as standard radiation therapy that can take as long as six weeks, according to new research findings.
April 28, 2010
For the first time, scientists have discovered a way to predict whether women with ductal carcinoma in situ (DCIS) – the most common form of non-invasive breast cancer – are at risk of developing more invasive tumors in later years.
March 16, 2010
UCSF researchers have discovered that a key cellular defect that disturbs the production of proteins in human cells can lead to cancer susceptibility. The scientists also found that a new generation of inhibitory drugs offers promise in correcting this defect.
February 24, 2010
Cancer researchers studying the immune system have identified a previously unrecognized set of targets and biomarkers to battle solid tumors.